Blue Trust Inc. cut its position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 8.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 3,888 shares of the company’s stock after selling 374 shares during the period. Blue Trust Inc.’s holdings in Bath & Body Works were worth $151,000 as of its most recent SEC filing.
Several other hedge funds have also modified their holdings of the company. Fifth Third Wealth Advisors LLC grew its stake in Bath & Body Works by 4.9% during the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock worth $271,000 after buying an additional 324 shares during the last quarter. TD Private Client Wealth LLC grew its stake in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after acquiring an additional 331 shares during the last quarter. UMB Bank n.a. increased its holdings in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares in the last quarter. Avior Wealth Management LLC raised its position in shares of Bath & Body Works by 30.3% in the 4th quarter. Avior Wealth Management LLC now owns 1,950 shares of the company’s stock valued at $76,000 after purchasing an additional 453 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Bath & Body Works by 34.4% in the 3rd quarter. GAMMA Investing LLC now owns 2,481 shares of the company’s stock valued at $79,000 after purchasing an additional 635 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research analysts have issued reports on BBWI shares. TD Cowen upped their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Morgan Stanley cut their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research report on Thursday, November 21st. Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a research report on Friday, January 10th. Telsey Advisory Group restated an “outperform” rating and issued a $42.00 price objective on shares of Bath & Body Works in a research note on Monday, November 25th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $43.19.
Bath & Body Works Stock Down 0.1 %
Bath & Body Works stock opened at $38.74 on Thursday. The company has a fifty day simple moving average of $37.72 and a 200-day simple moving average of $33.65. The firm has a market capitalization of $8.39 billion, a price-to-earnings ratio of 9.45, a PEG ratio of 1.01 and a beta of 1.83. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99.
Bath & Body Works (NYSE:BBWI – Get Free Report) last announced its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter in the prior year, the company earned $0.48 EPS. Bath & Body Works’s revenue was up 3.1% compared to the same quarter last year. On average, research analysts anticipate that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.07%. Bath & Body Works’s payout ratio is 19.51%.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Articles
- Five stocks we like better than Bath & Body Works
- What Investors Need to Know to Beat the Market
- 3 Must-Have ETFs Set to Dominate This Quarter
- How to buy stock: A step-by-step guide for beginners
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.